Latest News about JNJ
Recent news which mentions JNJ
Worried About a Stock Market Sell-Off? Consider Coca-Cola, Pepsi, and These 3 Safe Dividend Kings for Decades of Passive Income.
September 01, 2024
From Motley Fool
Johnson & Johnson-Spin Off Kenvue Wins Lawsuit Over Pain Killer Tylenol 'Rapid Release' Gelcaps
August 30, 2024
From Benzinga
Johnson & Johnson Seeks FDA Approval For Muscle Weakness Drug And Gears Up Showdown With Argenx and UCB
August 29, 2024
From Benzinga
Competitor Analysis: Evaluating Johnson & Johnson And Competitors In Pharmaceuticals Industry
August 29, 2024
From Benzinga
12 Dividend Stocks to Earn Income Every Month
August 28, 2024
From Motley Fool
3 Ways the Democratic Party's Platform Could Impact Biotech and Pharma Stocks if Implemented
August 27, 2024
From Motley Fool
Johnson Johnson-Partner Addex Therapeutics Selects Investigational Compound For Substance Use Disorder
August 27, 2024
From Benzinga
Jim Cramer Believes In Dell CEO, Doesn't Like B&G Foods
August 27, 2024
From Benzinga
Here Are 2 Great Vanguard Dividend ETFs: Which Is Right For You?
August 27, 2024
From Motley Fool
Meet Wall Street's Safest Dividend Stock: A Small-Cap Company Few Investors Know Exists
August 27, 2024
From Motley Fool
From Benzinga
Johnson & Johnson Seeks Resolution With Plaintiffs, Pushes To Finalize $6.5B Talc Settlement
August 26, 2024
From Benzinga
2 Unstoppable Stocks That Are Screaming Buys in August
August 26, 2024
From Motley Fool
Donald Trump Owns These 21 Dividend Kings. Should You?
August 26, 2024
From Motley Fool
A Big CEO Move, Big Buffett Buys, and More
August 22, 2024
From Motley Fool
From Motley Fool
From Benzinga
5 Dividend Growth Stocks to Buy and Hold Forever
August 19, 2024
From Motley Fool
3 High-Yield Dividend ETFs to Buy to Generate Passive Income
August 18, 2024
From Motley Fool
2 Dow Jones Dividend Stocks With Above-Average Yields to Buy Now and Hold for at Least a Decade
August 18, 2024
From Motley Fool
3 Top Dividend ETFs That Investors can Buy and Hold for Decades
August 16, 2024
From Motley Fool
From Benzinga
Comparative Study: Johnson & Johnson And Industry Competitors In Pharmaceuticals Industry
August 15, 2024
From Benzinga
From Benzinga
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
August 15, 2024
From InvestorPlace